| Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... Circulation 129 (3), 399-410, 2014 | 21558* | 2014 |
| Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... Circulation 131 (4), 434-441, 2015 | 15567 | 2015 |
| Heart disease and stroke statistics—2017 update EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... | 9910* | 2017 |
| General cardiovascular risk profile for use in primary care RB D’agostino, RS Vasan, MJ Pencina, PA Wolf, M Cobain, JM Massaro, ... Circulation 117 (6), 743-753, 2008 | 5651 | 2008 |
| American heart association statistics committee and stroke statistics subcommittee EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... Heart disease and stroke statistics-2017 update: a report from the American …, 2017 | 2769* | 2017 |
| CLINICAL PERSPECTIVE CS Fox, JM Massaro, U Hoffmann, KM Pou, P Maurovich-Horvat, CY Liu, ... Circulation 116 (1), 39-48, 2007 | 2544 | 2007 |
| Lifetime risk for development of atrial fibrillation: the Framingham Heart Study DM Lloyd-Jones, TJ Wang, EP Leip, MG Larson, D Levy, RS Vasan, ... Circulation 110 (9), 1042-1046, 2004 | 2438 | 2004 |
| Stent thrombosis in randomized clinical trials of drug-eluting stents L Mauri, W Hsieh, JM Massaro, KKL Ho, R D'Agostino, DE Cutlip New England journal of medicine 356 (10), 1020-1029, 2007 | 1783 | 2007 |
| Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp, DE Cutlip, PG Steg, ... New England Journal of Medicine 371 (23), 2155-2166, 2014 | 1620 | 2014 |
| Percutaneous repair or surgery for mitral regurgitation T Feldman, E Foster, DD Glower, S Kar, MJ Rinaldi, PS Fail, RW Smalling, ... New England Journal of Medicine 364 (15), 1395-1406, 2011 | 1600 | 2011 |
| Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study JF Keaney Jr, MG Larson, RS Vasan, PWF Wilson, I Lipinska, D Corey, ... Arteriosclerosis, thrombosis, and vascular biology 23 (3), 434-439, 2003 | 1551 | 2003 |
| Knowledge for what: The place of social science in American culture RS Lynd Princeton University Press, 2015 | 1365 | 2015 |
| Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study NS Rost, PA Wolf, CS Kase, M Kelly-Hayes, H Silbershatz, JM Massaro, ... Stroke 32 (11), 2575-2579, 2001 | 1113 | 2001 |
| Presentation of multivariate data for clinical use: The Framingham Study risk score functions LM Sullivan, JM Massaro, RB D'Agostino Sr Statistics in medicine 23 (10), 1631-1660, 2004 | 1090 | 2004 |
| Clinical perspective GA Rosito, JM Massaro, U Hoffmann, FL Ruberg, AA Mahabadi, ... Circulation 117 (5), 605-613, 2008 | 965 | 2008 |
| Closure or medical therapy for cryptogenic stroke with patent foramen ovale AJ Furlan, M Reisman, J Massaro, L Mauri, H Adams, GW Albers, ... New England Journal of Medicine 366 (11), 991-999, 2012 | 957 | 2012 |
| Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study RB Schnabel, LM Sullivan, D Levy, MJ Pencina, JM Massaro, ... The Lancet 373 (9665), 739-745, 2009 | 949 | 2009 |
| A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study TJ Wang, JM Massaro, D Levy, RS Vasan, PA Wolf, RB D'Agostino, ... Jama 290 (8), 1049-1056, 2003 | 925 | 2003 |
| Long-term results of carotid stenting versus endarterectomy in high-risk patients HS Gurm, JS Yadav, P Fayad, BT Katzen, GJ Mishkel, TK Bajwa, G Ansel, ... New England Journal of Medicine 358 (15), 1572-1579, 2008 | 869 | 2008 |
| CLINICAL PERSPECTIVE KM Pou, JM Massaro, U Hoffmann, RS Vasan, P Maurovich-Horvat, ... Circulation 116 (11), 1234-1241, 2007 | 867 | 2007 |
